CIBC Bancorp USA Inc. Makes New Investment in Cigna Group $CI

CIBC Bancorp USA Inc. purchased a new stake in Cigna Group (NYSE:CI) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 36,834 shares of the health services provider’s stock, valued at approximately $10,617,000.

Several other large investors have also modified their holdings of the stock. Harbor Capital Advisors Inc. boosted its position in shares of Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after acquiring an additional 49 shares during the last quarter. Collier Financial acquired a new position in Cigna Group during the third quarter worth approximately $34,000. Founders Capital Management increased its position in Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock worth $44,000 after purchasing an additional 53 shares during the last quarter. Traub Capital Management LLC purchased a new position in Cigna Group during the second quarter worth approximately $48,000. Finally, Twin Peaks Wealth Advisors LLC purchased a new position in Cigna Group during the second quarter worth approximately $52,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Up 0.0%

NYSE CI opened at $264.72 on Friday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The business has a 50 day moving average price of $278.19 and a two-hundred day moving average price of $281.97. The stock has a market cap of $69.76 billion, a PE ratio of 11.94, a P/E/G ratio of 0.92 and a beta of 0.27.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

Insiders Place Their Bets

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares in the company, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on CI. Leerink Partners boosted their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Mizuho set a $325.00 target price on Cigna Group in a research report on Friday, January 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. Robert W. Baird lowered their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating for the company in a research report on Thursday, December 11th. Finally, Wall Street Zen upgraded Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.